Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
NCT ID | NCT04148937 |
Title | A Study of the CD73 Inhibitor LY3475070 Alone or in Combination With Pembrolizumab in Participants With Advanced Cancer |
Recruitment | Completed |
Gender | both |
Phase | Phase I |
Variant Requirements | No |
Sponsors | Eli Lilly and Company |
Indications | |
Therapies | |
Age Groups: | adult | senior |
Covered Countries | USA | GBR | AUS |
Facility | Status | City | State | Zip | Country | Details |
---|---|---|---|---|---|---|
Sarah Cannon Research Institute at HealthOne | Denver | Colorado | 80218 | United States | Details | |
Florida Cancer Specialists ORLANDO/DDU | Lake Mary | Florida | 32746 | United States | Details | |
START Midwest | Grand Rapids | Michigan | 49546 | United States | Details | |
Washington University Medical School | Saint Louis | Missouri | 63110 | United States | Details | |
Cleveland Clinic Foundation | Cleveland | Ohio | 44195 | United States | Details | |
Sarah Cannon Research Institute SCRI | Nashville | Tennessee | 37203 | United States | Details | |
University of Texas MD Anderson Cancer Center | Houston | Texas | 77030 | United States | Details | |
Peter MacCallum Cancer Centre | Melbourne | Victoria | 3000 | Australia | Details | |
Addenbrookes Hospital | Cambridge | Cambridgeshire | CB2 0QQ | United Kingdom | Details | |
Beatson West of Scotland Cancer Center | Glasgow | Scotland | G12 0YN | United Kingdom | Details | |
Christie NHS Foundation Trust | Manchester | M20 4 BX | United Kingdom | Details | ||
Royal Marsden NHS Trust | Sutton | SM2 5PT | United Kingdom | Details |